-
FDA declines to grant EUA for NRx’s Zyesami to treat Covid-19 patients
Pharmaceutical-Technology
November 08, 2021
The US Food and Drug Administration (FDA) has declined to grant an emergency use authorization (EUA) for NRx Pharmaceuticals’ therapy, Zyesami (aviptadil), to treat critical Covid-19 patients who have respiratory failure.
-
US authorises more batches of J&J COVID-19 vaccine made at Emergent
ExpressPharma
November 08, 2021
The US Food and Drug Administration (FDA) said it had authorised the use of two more batches of Johnson & Johnson’s one-dose COVID-19 vaccine manufactured at the problem-plagued Baltimore...
-
AHA News: What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-Olds
Drugs
November 08, 2021
A COVID-19 vaccine has finally arrived for children ages 5 to 11 – and with it, some important questions from parents.
-
Insulin Rx Fills Down During the Pandemic
Drugs
November 08, 2021
There has been a considerable decrease in the average number of weekly insulin prescription fills during the COVID-19 pandemic, according to a research letter published online Nov. 3 in JAMA Network Open.
-
Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89 Percent
Drugs
November 08, 2021
Pfizer Inc. announced Friday that its experimental COVID-19 pill slashed the risk of hospitalization and death by 89 percent in infected high-risk people.
-
Cigna Study Shows Hongkongers Ranked the Sixth Most Stressed Population Globally
prnasia
November 08, 2021
Cigna Hong Kong, S.A.R., China released today the Hong Kong, S.A.R., China findings of the latest Cigna 360 Well-Being Survey. This research is the seventh in a series of studies, which aims to better understand the impact of the COVID-19...
-
Chinese mainland reports 68 locally transmitted COVID-19 cases
NMPA
November 08, 2021
BEIJING -- The Chinese mainland on Thursday reported 68 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 5.
-
FDA provides EUA for Pfizer-BioNTech’s Covid-19 vaccine in children
Pharmaceutical-Business-Review
November 05, 2021
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Pfizer-BioNTech’s Covid-19 vaccine for children aged 5 to 11 years.
-
WHO grants emergency use listing to Bharat Biotech’s Covaxin
Pharmaceutical-Technology
November 05, 2021
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) to Indian company Bharat Biotech’s Covid-19 vaccine, Covaxin, for use in individuals aged 18 years and above.
-
UK grants world-first approval to Covid-19 pill molnupiravir
Pharmaceutical-Technology
November 05, 2021
The first oral antiviral to treat Covid-19, Merck and Ridgeback Biotherapeutics’ molnupiravir, has been approved by the UK drugs regulator.